Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Organic Cation Transporter 3 Facilitates Fetal Exposure to Metformin During Pregnancy.

Lee N, Hebert MF, Wagner DJ, Easterling TR, Liang CJ, Rice K, Wang J.

Mol Pharmacol. 2018 Jul 16. pii: mol.118.112482. doi: 10.1124/mol.118.112482. [Epub ahead of print]

2.

Prednisone Pharmacokinetics During Pregnancy and Lactation.

Ryu RJ, Easterling TR, Caritis SN, Venkataramanan R, Umans JG, Ahmed MS, Clark S, Kantrowitz-Gordon I, Hays K, Bennett B, Honaker MT, Thummel KE, Shen DD, Hebert MF.

J Clin Pharmacol. 2018 May 7. doi: 10.1002/jcph.1122. [Epub ahead of print]

PMID:
29733485
3.

Pharmacokinetics of dacarbazine (DTIC) in pregnancy.

Kantrowitz-Gordon I, Hays K, Kayode O, Kumar AR, Kaplan HG, Reid JM, Safgren SL, Ames MM, Easterling TR, Hebert MF.

Cancer Chemother Pharmacol. 2018 Mar;81(3):455-460. doi: 10.1007/s00280-017-3511-6. Epub 2018 Jan 5.

PMID:
29305638
4.

Nephrotic syndrome in pregnancy poses risks with both maternal and fetal complications.

De Castro I, Easterling TR, Bansal N, Jefferson JA.

Kidney Int. 2017 Jun;91(6):1464-1472. doi: 10.1016/j.kint.2016.12.019. Epub 2017 Feb 21.

PMID:
28233609
5.

Pregnancy Increases the Renal Secretion of N1-methylnicotinamide, an Endogenous Probe for Renal Cation Transporters, in Patients Prescribed Metformin.

Bergagnini-Kolev MC, Hebert MF, Easterling TR, Lin YS.

Drug Metab Dispos. 2017 Mar;45(3):325-329. doi: 10.1124/dmd.116.073841. Epub 2017 Jan 9.

6.

Post-Control of Hypertension in Pregnancy Study (CHIPS): What Is the Optimal Strategy to Manage Hypertension During Pregnancy?

Easterling TR.

Hypertension. 2016 Jul;68(1):36-8. doi: 10.1161/HYPERTENSIONAHA.116.07190. Epub 2016 May 16. No abstract available.

7.

Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial.

Costantine MM, Cleary K, Hebert MF, Ahmed MS, Brown LM, Ren Z, Easterling TR, Haas DM, Haneline LS, Caritis SN, Venkataramanan R, West H, D'Alton M, Hankins G; Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric-Fetal Pharmacology Research Units Network.

Am J Obstet Gynecol. 2016 Jun;214(6):720.e1-720.e17. doi: 10.1016/j.ajog.2015.12.038. Epub 2015 Dec 23.

8.

Pharmacokinetics of metoprolol during pregnancy and lactation.

Ryu RJ, Eyal S, Easterling TR, Caritis SN, Venkataraman R, Hankins G, Rytting E, Thummel K, Kelly EJ, Risler L, Phillips B, Honaker MT, Shen DD, Hebert MF.

J Clin Pharmacol. 2016 May;56(5):581-9. doi: 10.1002/jcph.631. Epub 2015 Dec 4.

9.

Apheresis to Treat Preeclampsia: Insights, Opportunities and Challenges.

Easterling TR.

J Am Soc Nephrol. 2016 Mar;27(3):663-5. doi: 10.1681/ASN.2015070794. Epub 2015 Sep 24. No abstract available.

10.

Population pharmacokinetics of oseltamivir in non-pregnant and pregnant women.

Pillai VC, Han K, Beigi RH, Hankins GD, Clark S, Hebert MF, Easterling TR, Zajicek A, Ren Z, Caritis SN, Venkataramanan R.

Br J Clin Pharmacol. 2015 Nov;80(5):1042-50. doi: 10.1111/bcp.12691. Epub 2015 Aug 18.

11.

Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.

Barry DR, Utzschneider KM, Tong J, Gaba K, Leotta DF, Brunzell JD, Easterling TR.

Am J Obstet Gynecol. 2015 Jul;213(1):104.e1-11. doi: 10.1016/j.ajog.2015.05.040. Epub 2015 May 21.

12.

Transjugular Intrahepatic Portosystemic Shunt Placement During Pregnancy: A Case Series of Five Patients.

Ingraham CR, Padia SA, Johnson GE, Easterling TR, Liou IW, Kanal KM, Valji K.

Cardiovasc Intervent Radiol. 2015 Oct;38(5):1205-10. doi: 10.1007/s00270-015-1053-z. Epub 2015 Jan 24.

PMID:
25613670
13.

Pharmacological management of hypertension in pregnancy.

Easterling TR.

Semin Perinatol. 2014 Dec;38(8):487-95. doi: 10.1053/j.semperi.2014.08.016. Epub 2014 Oct 11. Review.

14.

Pharmacokinetics of doxorubicin in pregnant women.

Ryu RJ, Eyal S, Kaplan HG, Akbarzadeh A, Hays K, Puhl K, Easterling TR, Berg SL, Scorsone KA, Feldman EM, Umans JG, Miodovnik M, Hebert MF.

Cancer Chemother Pharmacol. 2014 Apr;73(4):789-97. doi: 10.1007/s00280-014-2406-z. Epub 2014 Feb 15.

15.

Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancy.

Lee N, Hebert MF, Prasad B, Easterling TR, Kelly EJ, Unadkat JD, Wang J.

Drug Metab Dispos. 2013 Dec;41(12):2225-32. doi: 10.1124/dmd.113.054072. Epub 2013 Oct 7.

16.

The brain study: Cognition, quality of life and social functioning following preeclampsia; An observational study.

Postma IR, Groen H, Easterling TR, Tsigas EZ, Wilson ML, Porcel J, Zeeman GG.

Pregnancy Hypertens. 2013 Oct;3(4):227-34. doi: 10.1016/j.preghy.2013.06.003. Epub 2013 Jun 24.

PMID:
26103801
17.

Tacrolimus placental transfer at delivery and neonatal exposure through breast milk.

Zheng S, Easterling TR, Hays K, Umans JG, Miodovnik M, Clark S, Calamia JC, Thummel KE, Shen DD, Davis CL, Hebert MF.

Br J Clin Pharmacol. 2013 Dec;76(6):988-96. doi: 10.1111/bcp.12122.

18.

Interpreting tacrolimus concentrations during pregnancy and postpartum.

Hebert MF, Zheng S, Hays K, Shen DD, Davis CL, Umans JG, Miodovnik M, Thummel KE, Easterling TR.

Transplantation. 2013 Apr 15;95(7):908-15. doi: 10.1097/TP.0b013e318278d367. Review.

19.

Maternal, perinatal, and postneonatal outcomes in women with chronic heart disease in Washington State.

Leary PJ, Leary SE, Stout KK, Schwartz SM, Easterling TR.

Obstet Gynecol. 2012 Dec;120(6):1283-90. doi: http://10.1097/AOG.0b013e3182733d56.

20.

Pharmacokinetics of tacrolimus during pregnancy.

Zheng S, Easterling TR, Umans JG, Miodovnik M, Calamia JC, Thummel KE, Shen DD, Davis CL, Hebert MF.

Ther Drug Monit. 2012 Dec;34(6):660-70. doi: 10.1097/FTD.0b013e3182708edf.

21.

Gestational diabetes or lesser degrees of glucose intolerance and risk of preeclampsia.

Carr DB, Newton KM, Utzschneider KM, Faulenbach MV, Kahn SE, Easterling TR, Heckbert SR.

Hypertens Pregnancy. 2011;30(2):153-63. doi: 10.3109/10641950903115012. Epub 2010 Dec 21.

PMID:
21174585
22.

Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth.

Rothberger S, Carr D, Brateng D, Hebert M, Easterling TR.

Am J Hypertens. 2010 Nov;23(11):1234-40. doi: 10.1038/ajh.2010.159. Epub 2010 Aug 19.

23.

CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance.

Claessens AJ, Risler LJ, Eyal S, Shen DD, Easterling TR, Hebert MF.

Drug Metab Dispos. 2010 Sep;38(9):1393-6. doi: 10.1124/dmd.110.033878. Epub 2010 Jun 22.

24.

Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum.

Eyal S, Kim JD, Anderson GD, Buchanan ML, Brateng DA, Carr D, Woodrum DE, Easterling TR, Hebert MF.

J Clin Pharmacol. 2010 Nov;50(11):1301-9. doi: 10.1177/0091270009358708. Epub 2010 Feb 9.

25.

Pharmacokinetics of metformin during pregnancy.

Eyal S, Easterling TR, Carr D, Umans JG, Miodovnik M, Hankins GD, Clark SM, Risler L, Wang J, Kelly EJ, Shen DD, Hebert MF.

Drug Metab Dispos. 2010 May;38(5):833-40. doi: 10.1124/dmd.109.031245. Epub 2010 Jan 29.

26.

Preeclampsia and risk of developing subsequent diabetes.

Carr DB, Newton KM, Utzschneider KM, Tong J, Gerchman F, Kahn SE, Easterling TR, Heckbert SR.

Hypertens Pregnancy. 2009 Aug;28(4):435-47. doi: 10.3109/10641950802629675.

PMID:
19843005
27.

Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice.

Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, Caritis SN, Miodovnik M, Mattison DR, Unadkat JD, Kelly EJ, Blough D, Cobelli C, Ahmed MS, Snodgrass WR, Carr DB, Easterling TR, Vicini P; Obstetric-Fetal Pharmacology Research Unit Network.

Clin Pharmacol Ther. 2009 Jun;85(6):607-14. doi: 10.1038/clpt.2009.5. Epub 2009 Mar 18.

28.

Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy.

Carr DB, Tran LT, Brateng DA, Kawamura C, Shofer JB, Karumanchi SA, Easterling TR.

Hypertens Pregnancy. 2009 Feb;28(1):42-55. doi: 10.1080/10641950802132803.

PMID:
19165669
29.

Clonidine pharmacokinetics in pregnancy.

Buchanan ML, Easterling TR, Carr DB, Shen DD, Risler LJ, Nelson WL, Mattison DR, Hebert MF.

Drug Metab Dispos. 2009 Apr;37(4):702-5. doi: 10.1124/dmd.108.024984. Epub 2008 Dec 30.

30.

The impact of duration of labor induction on cesarean rate.

Michelson KA, Carr DB, Easterling TR.

Am J Obstet Gynecol. 2008 Sep;199(3):299.e1-4. doi: 10.1016/j.ajog.2008.06.072.

PMID:
18771990
31.

Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study.

Hebert MF, Easterling TR, Kirby B, Carr DB, Buchanan ML, Rutherford T, Thummel KE, Fishbein DP, Unadkat JD.

Clin Pharmacol Ther. 2008 Aug;84(2):248-53. doi: 10.1038/clpt.2008.1. Epub 2008 Feb 20.

PMID:
18288078
32.

Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network study.

Naraharisetti SB, Kirby BJ, Hebert MF, Easterling TR, Unadkat JD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Dec 1;860(1):34-41. Epub 2007 Oct 22.

33.

Induction of labor in the absence of standard medical indications: incidence and correlates.

Lydon-Rochelle MT, Cárdenas V, Nelson JC, Holt VL, Gardella C, Easterling TR.

Med Care. 2007 Jun;45(6):505-12.

PMID:
17515777
34.

Maternal hemodynamic changes associated with furosemide treatment.

Carr DB, Gavrila D, Brateng D, Easterling TR.

Hypertens Pregnancy. 2007;26(2):173-8.

PMID:
17469007
35.

Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies.

Andrew MA, Easterling TR, Carr DB, Shen D, Buchanan ML, Rutherford T, Bennett R, Vicini P, Hebert MF.

Clin Pharmacol Ther. 2007 Apr;81(4):547-56. Epub 2007 Feb 28.

PMID:
17329990
36.

Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery.

Carr DB, Koontz GL, Gardella C, Holing EV, Brateng DA, Brown ZA, Easterling TR.

Am J Hypertens. 2006 May;19(5):513-9.

PMID:
16647626
37.

Repeat cesarean delivery: what indications are recorded in the medical chart?

Lydon-Rochelle MT, Gardella C, Cárdenas V, Easterling TR.

Birth. 2006 Mar;33(1):4-11.

PMID:
16499526
38.

Detecting small for gestational age infants: the development of a population-based reference for Washington state.

Lipsky S, Easterling TR, Holt VL, Critchlow CW.

Am J Perinatol. 2005 Nov;22(8):405-12.

PMID:
16283599
39.

Accuracy of reporting maternal in-hospital diagnoses and intrapartum procedures in Washington State linked birth records.

Lydon-Rochelle MT, Holt VL, Nelson JC, Cárdenas V, Gardella C, Easterling TR, Callaghan WM.

Paediatr Perinat Epidemiol. 2005 Nov;19(6):460-71.

PMID:
16269074
40.

Validity of maternal and perinatal risk factors reported on fetal death certificates.

Lydon-Rochelle MT, Cárdenas V, Nelson JL, Tomashek KM, Mueller BA, Easterling TR.

Am J Public Health. 2005 Nov;95(11):1948-51. Epub 2005 Sep 29.

41.

A sister's risk: family history as a predictor of preeclampsia.

Carr DB, Epplein M, Johnson CO, Easterling TR, Critchlow CW.

Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):965-72.

PMID:
16157095
42.

Police-reported intimate partner violence during pregnancy: who is at risk?

Lipsky S, Holt VL, Easterling TR, Critchlow CW.

Violence Vict. 2005 Feb;20(1):69-86.

PMID:
16047936
43.

The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data.

Lydon-Rochelle MT, Holt VL, Cárdenas V, Nelson JC, Easterling TR, Gardella C, Callaghan WM.

Am J Obstet Gynecol. 2005 Jul;193(1):125-34.

PMID:
16021070
44.

Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum.

Hebert MF, Carr DB, Anderson GD, Blough D, Green GE, Brateng DA, Kantor E, Benedetti TJ, Easterling TR.

J Clin Pharmacol. 2005 Jan;45(1):25-33.

PMID:
15601802
45.

Police-reported intimate partner violence during pregnancy and the risk of antenatal hospitalization.

Lipsky S, Holt VL, Easterling TR, Critchlow CW.

Matern Child Health J. 2004 Jun;8(2):55-63.

PMID:
15198172
46.

Cardiovascular and thromboembolic events following hypertensive pregnancy.

Kestenbaum B, Seliger SL, Easterling TR, Gillen DL, Critchlow CW, Stehman-Breen CO, Schwartz SM.

Am J Kidney Dis. 2003 Nov;42(5):982-9.

PMID:
14582042
47.

Impact of police-reported intimate partner violence during pregnancy on birth outcomes.

Lipsky S, Holt VL, Easterling TR, Critchlow CW.

Obstet Gynecol. 2003 Sep;102(3):557-64.

PMID:
12962943
48.

A report of dizygous monochorionic twins.

Souter VL, Kapur RP, Nyholt DR, Skogerboe K, Myerson D, Ton CC, Opheim KE, Easterling TR, Shields LE, Montgomery GW, Glass IA.

N Engl J Med. 2003 Jul 10;349(2):154-8. No abstract available.

49.

Treatment for chronic, mild-to-moderate hypertension and pregnancy: what does the evidence say?

Rosene-Montella K, Easterling TR, Lee RV.

J Obstet Gynaecol. 2001 Jul;21(4):335-9. No abstract available.

PMID:
12521821
50.

The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia.

Carr DB, McDonald GB, Brateng D, Desai M, Thach CT, Easterling TR.

Obstet Gynecol. 2001 Dec;98(6):1109-16.

PMID:
11755562

Supplemental Content

Loading ...
Support Center